Physician profile
Stephen Bader
NPI 1619911591
$35,940.72
in general payments reported to CMS, 2019-2025
14 companies · $99.09 in 2025
The $99.09 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $8,521 · 2021: $3,555 · 2022: $46.39 · 2023: $333 · 2024: $2,468 · 2025: $99.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $450 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $450.29 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $14,829.83 | 2019-2020 | |
| Grifols USA, LLC | $14,800.00 | 2019-2024 | Thrombate III |
| Medtronic, INC. | $3,700.00 | 2021-2024 | |
| Edwards Lifesciences Corporation | $1,606.02 | 2019 | |
| Merz North America, INC. | $494.49 | 2021-2023 | Xeomin |
| Pacira Pharmaceuticals Incorporated | $195.48 | 2019-2025 | Exparel, Iovera, Zilretta |
| Merck Sharp & Dohme LLC | $128.65 | 2022-2025 | Bridion |
| Grifols Shared Services North America, INC. | $53.50 | 2019 | |
| Hemosonics LLC | $39.70 | 2020 | |
| Ambu INC. | $24.99 | 2025 | |
| Baxter Healthcare | $19.29 | 2023 | Floseal |
| Ferring Pharmaceuticals INC. | $19.13 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.83 | 2021 | |
| Abbott Laboratories | $14.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.